AGM
ADIL

Alpine Global Management’s Adial Pharmaceuticals ADIL Stock Holding History

Alpine Global Management’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61
Closed -$85K – 204
2020
Q3 		$85K Buy
+61
New +$56.8K 0.02% 202

Other funds holding ADIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Alpine Global Management's ADIL Position: Q4 2020 in Review

Alpine Global Management sold out of Adial Pharmaceuticals (ADIL) in Q4 2020, closing a stake of 61 shares — an estimated $85K sold.

Alpine Global Management first reported a position in ADIL in Q3 2020 and held it in 1 quarter. The position peaked at $85K in Q3 2020. 13 funds tracked by Wall St. Rank hold ADIL as of Q4 2020.

  • Alpine Global Management reported no remaining Adial Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Alpine Global Management sold 61 Adial Pharmaceuticals shares in Q4 2020, an estimated $85K.
  • Alpine Global Management first reported a position in Adial Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Alpine Global Management's Adial Pharmaceuticals position peaked at $85K in Q3 2020.
  • 13 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q4 2020.

Based on Alpine Global Management's 13F filing for Q4 2020, filed 12 Feb 2021.